New thumb implant aims to ease arthritis pain and restore grip

NCT ID NCT06546306

Ongoing Disease control Sponsor: Keri Medical SA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new thumb joint replacement called the Touch® prosthesis in 216 adults with severe thumb osteoarthritis. The implant is designed to reduce pain and improve thumb mobility. Researchers will check how well it works and how safe it is over time, starting at 3 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Touch® dual mobility trapeziometacarpal prosthesis (a thumb joint replacement implant)
What this could lead to: If successful, this implant could offer a reliable option to reduce pain and restore thumb function for people with severe thumb osteoarthritis.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. Risks include surgery complications, implant failure, or ongoing pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS THUMB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hand

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEOARTHRITIS THUMB

Contacts and locations

Locations

Centre de la main du Pays d'Aix

Aix-en-Provence, 13090, France
Clinic of Chataigneraie

Beaumont, 63110, France
Medical Office Archimed

Lesquin, 59810, France
Medical Office of Dr TCHURUKDICHIAN

Dijon, 21000, France
Médipôle De Savoie

Challes-les-Eaux, 73190, France
Orthopaedics and Trauma Surgery Practice

Bezannes, 51430, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.